Breaking News, Collaborations & Alliances

ProBioGen Closes Master Service Agreement with NextPoint

Initiates development and GMP manufacturing of NextPoint’s lead antibody candidate.

Author Image

By: Charlie Sternberg

Associate Editor

ProBioGen has closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.   ProBioGen’s CHO.RiGHT cell line development including its latest DirectedLuck transposase and platform processes enable the development to provide a high-expressing stable cell line and a robust manufacturing process. Further, ProBioGen’s proprietary cell culture medium makes manufacturing processes even more robust, with improved protei...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters